Viewing Study NCT00483665



Ignite Creation Date: 2024-05-05 @ 5:35 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00483665
Status: COMPLETED
Last Update Posted: 2008-11-19
First Post: 2007-06-06

Brief Title: Vasovist Endoleak Study
Sponsor: UMC Utrecht
Organization: UMC Utrecht

Study Overview

Official Title: Detection of Endoleak by Vasovist-Enhanced Magnetic Resonance Imaging
Status: COMPLETED
Status Verified Date: 2008-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: After endovascular treatment of an abdominal aortic aneurysm lifelong imaging follow-up is needed to monitor the effectiveness of the treatment One parameter in this follow-up is endoleak which is leakage of blood into the aneurysm sac The aim of this study is to investigate the value of magnetic resonance imaging using Vasovist as a contrast agent for the detection of endoleaks
Detailed Description: After endovascular abdominal aortic aneurysm repair life-long follow-up is needed to monitor the effectiveness of exclusion of the aneurysm sac from blood flow For this reason aneurysm diameter and the presence of endoleaks is evaluated with computed tomographic CT angiography yearly after Endovascular Aneurysm Repair EVAR

The aim of this study is to investigate the value of magnetic resonance imaging using Vasovist as a contrast agent for the detection of endoleaks

The advantages of magnetic resonance imaging with respect to CTA are no use of ionizing radiation use of less nephrotoxic contrast agents

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None